ReviewProbiotics and antimicrobial proteins2026
Hormonal Imbalance and Gut Dysbiosis: Emerging Perspectives in Women's Health.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The gut microbiota plays a crucial function in reproductive well-being and is vital for maintaining fundamental physiological balance. This article surveys the mutual relationships between the gut flora and the female reproductive system, which are maintained through metabolic, immunological, and neuroendocrine mechanisms, thereby creating the gastrointestinal-reproductive axis. Dysbiosis, which results from an imbalance in microbial levels, has been related with reproductive diseases, such as polycystic ovary syndrome (PCOS), infertility, endometriosis, and pregnancy-related problems. Modulation of the gut microbiota via targeted synthetic materials, such as metformin, dietary phytocompounds, synbiotics, probiotics, and prebiotics, affects hormonal levels, glucose resistance, and monthly cycle regulation, showcasing favorable prospects for medical care. This review elucidates the molecular and cellular processes underlying gut-reproductive relationships and assesses the potential of microbiome-targeted medications as viable clinical approaches for enhancing fertility outcomes. Further attention should be devoted to determining the crosstalk between endometrial disruption, hormonal imbalance, and inflammation.
Indexed as
Identifiers
42322535What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.